Shawn T McCormick has served as a member of our Board since January 2017. Mr. McCormick served as Chief Financial Officer of Aldevron, LLC, a technology company specializing in the manufacture of plasmid DNA, mRNA and proteins, from November 2020 to February 2022. Aldevron was acquired by Danaher Corporation in August 2021. Previously, Mr. McCormick served as Chief Financial Officer of Tornier N.V., a global orthopedic company, from 2012 until 2015 when Tornier merged with Wright Medical Group, Inc. Before Tornier, Mr. McCormick served as Chief Operating Officer of Lutonix, Inc., a medical device company, from 2011 to 2012, and as Chief Financial Officer and Senior Vice President of ev3 Inc., a global endovascular company, from 2009 to 2010, when ev3 was acquired by Covidien plc. From 1992 to 2009, Mr. McCormick held various positions at Medtronic plc, including as its Vice President, Corporate Development, where he was responsible for leading Medtronic's worldwide business development activities, and Vice President of Finance for the Spinal, Biologics and Navigation business. In addition to serving on our Board, Mr. McCormick has served on the board of directors of Nevro Corp. since 2014. Mr. McCormick also served on the board of directors of Entellus Medical, Inc. from 2014 to February 2018, and Surmodics, Inc. from 2015 to December 2020. Mr. McCormick holds a B.S. in Accounting from Arizona State University and an M.B.A. from the University of Minnesota's Carlson School of Management and is a Certified Public Accountant (inactive). We believe Mr. McCormick's financial expertise and extensive experience in the medical device industry enable him to make valuable contributions to our Board.
What is Shawn McCormick's net worth?
The estimated net worth of Shawn McCormick is at least $3.65 million as of November 28th, 2025. Mr. McCormick owns 26,046 shares of Inspire Medical Systems stock worth more than $3,654,358 as of December 4th. This net worth approximation does not reflect any other assets that Mr. McCormick may own. Learn More about Shawn McCormick's net worth.
How do I contact Shawn McCormick?
Has Shawn McCormick been buying or selling shares of Inspire Medical Systems?
In the last ninety days, Shawn McCormick has sold $254,960.00 of Inspire Medical Systems stock. Most recently, Shawn Mccormick sold 2,000 shares of the business's stock in a transaction on Friday, November 28th. The shares were sold at an average price of $127.48, for a transaction totalling $254,960.00. Following the completion of the sale, the director now directly owns 26,046 shares of the company's stock, valued at $3,320,344.08. Learn More on Shawn McCormick's trading history.
Who are Inspire Medical Systems' active insiders?
Inspire Medical Systems' insider roster includes Randy Ban (Insider), Richard Buchholz (CFO), Philip Ebeling (COO), Jerry Griffin (Director), Timothy Herbert (CEO), Steven Jandrich (VP), Chau Khuong (Director), Shawn McCormick (Director), Georgia Melenikiotou (Director), Marilyn Nelson (Director), John Rondoni (CTO), and Casey Tansey (Director). Learn More on Inspire Medical Systems' active insiders.
Are insiders buying or selling shares of Inspire Medical Systems?
In the last year, Inspire Medical Systems insiders bought shares 2 times. They purchased a total of 5 shares worth more than $803.62. In the last year, insiders at the sold shares 8 times. They sold a total of 39,591 shares worth more than $6,146,995.23. The most recent insider tranaction occured on November, 28th when Director Shawn Mccormick sold 2,000 shares worth more than $254,960.00. Insiders at Inspire Medical Systems own 4.1% of the company.
Learn More about insider trades at Inspire Medical Systems. Information on this page was last updated on 11/28/2025.
